MedTrace Logo

Mobile Technology for Reducing and Preventing Adolescent Suicide

NCT04896593 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2023-03-30

Study results available
· View outcomes & findings →

Summary

This single-group open-label trial will evaluate the feasibility and preliminary efficacy of a suicide prevention mobile application when used as an adjunct to usual care in adolescents.

Conditions

Interventions

BEHAVIORAL

Smartphone App

Smartphone app teaching suicide prevention skills.

Sponsors & Collaborators

  • Oui Therapeutics, Inc.

    collaborator INDUSTRY

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Hartford Hospital

    lead OTHER

Principal Investigators

  • David Tolin, Ph.D. · Institute of Living/Hartford Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-12
Primary Completion
2022-05-25
Completion
2022-05-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04896593 on ClinicalTrials.gov